See prescribing information, including boxed warning. Patients taking austedo xr® (deutetrabenazine) tablets to treat hd chorea saw symptom improvements in 12 weeks See safety info and boxed warning. Austedo (deutetrabenazine) is a reversible inhibitor of the vesicular monoamine transporter 2 (vmat2) used to treat chorea in huntington's disease and tardive dyskinesia, with a recommended treatment approach based on the american psychiatric association's guidelines for managing tardive dyskinesia associated with antipsychotic therapy 1. The majority of people with td or chorea associated with huntington disease (hd) who were treated with austedo xr (deutetrabenazine Clinical study details for austedo xr® (deutetrabenazine) once daily tablets treatment for huntington's disease chorea
WATCH
